Latest
Popular
Biomedical Advances
RAS(ON) inhibitor doubles median survival in phase 3 metastatic pancreatic cancer trial
In a phase 3 trial for metastatic pancreatic cancer, the RAS inhibitor daraxonrasib significantly improved overall and progression-free survival compared to chemotherapy, with a manageable safety profile and no unexpected…
Diet and Lifestyle
Colorectal cancer risk linked to gut microbiome alterations
More than ten years after colorectal adenoma removal, the gut microbiome partially resembles that of colorectal cancer patients and shows a stronger association with diet and lifestyle compared to individuals…
Preventive Medicine
The cost of delaying childhood hepatitis B vaccination
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life. …























